NCCN Guidelines® Insights - Central Nervous System Cancers, Version 2.2014
The NCCN Guidelines for Central Nervous System Cancers provide multidisciplinary recommendations on the clinical management of patients with cancers of the central nervous system. This NCCN Guidelines Insights highlight recent updates regarding the management of metastatic brain tumors using radiation therapy. Use of stereotactic radiosurgery (SRS) is no longer limited to patients with 3 or fewer lesions, becasue data suggest that total disease burden, rather than number of lesions, is predictive of survival benefits associated with the technique. SRS is increasingly becoming an integral part of management of patients with controlled, low-volume brain metastases.
This activity has been designated to meet the educational needs of physicians, nurses, and pharmacists involved in the management of patients with cancer.
Upon completion of this activity, participants will be able to:
- Integrate into professional practice the updates to NCCN Guidelines for Central Nervous System Cancers
- Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Central Nervous System Cancers
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician